Bandaram Pharma Packtech Posts Consolidated Q2 Profit

Consolidated Profit: Rs 18.61 Lakhs | Standalone Loss: Rs 41.04 Lakhs

Reader Takeaway: Subsidiaries sustain group profitability while the parent company struggles with persistent standalone losses this quarter.

What just happened

Bandaram Pharma Packtech Ltd announced its audited financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated net profit of Rs 18.61 lakhs for the quarter, supported by a revenue of Rs 2,145.02 lakhs. In contrast, the standalone entity reported a net loss of Rs 41.04 lakhs on revenue of Rs 236.61 lakhs.

Why this matters

The results highlight a significant divergence between the performance of the parent entity and its subsidiaries. The company’s consolidated bottom line is currently reliant on the contributions from VSR Paper and Packaging Limited (51.08% stake) and Craftsmart Products Private Limited (100% stake). Investors need to weigh the stability of these subsidiaries against the ongoing losses reported at the standalone level.

Contextual Performance

On a consolidated basis, the profit of Rs 18.61 lakhs for the September quarter shows an improvement compared to the Rs 6.03 lakhs profit reported in the same quarter last year, though it reflects a decline from the Rs 68.44 lakhs profit recorded in the preceding quarter (ended June 30, 2026). The standalone business continues to see widening losses, increasing from Rs 34.78 lakhs in the year-ago period to Rs 41.04 lakhs this quarter.

What to track next

Shareholders should monitor management's strategy for achieving operational efficiency at the parent company level. Since the company does not report by segment under Ind AS-108, assessing the specific growth drivers of the subsidiary entities will be key to understanding the group's overall trajectory.